The U.S. Food and Drug Administration said on Monday it will not take action against compounding pharmacies making copies of ...

The large inflow of cash from Comirnaty gross profits in 2021-22 has further secured BioNTech's financial health. Outside of BioNTech’s covid-19 vaccine candidates, we think the earliest approval ...

The diabetes and weight loss drug market is heating up in 2025, with significant growth signs everywhere. According to a recent study from Research and Markets, industry growth is running at an ...

Redwire Corporation (NYSE: RDW, the "Company"), a leader in space infrastructure for the next generation space economy, today ...

Electric-vehicle maker Tesla was down 3.7% after UBS cut its forecast for the automaker's first-quarter deliveries and ...

Stock futures fell again Monday, after the S&P 500 had its worst week in months amid fears about President Donald Trump's ...

Yahoo Finance will chronicle the latest news and updates on Trump's tariffs — from the threats to the eventual policy.

Eli Lilly plans to launch Mounjaro, its blockbuster diabetes drug, in countries like China, India, Brazil and Mexico by 2026, ...

Eli Lilly (NYSE: LLY) stock has had plenty of good trading sessions over the past year or so, but Monday's sure wasn't among them. The storied pharmaceutical company's shares lost nearly 5% of their ...

Presiding over the upward trajectory of Eli Lilly over the last eight years is paying off nicely for CEO David Ricks. | ...

Yahoo Finance will chronicle the latest news and updates on Trump's tariffs — from the threats to the eventual policy.